Safety & Effectiveness on Vascular Structure and Function of ACZ885 in Atherosclerosis and Either T2DM or IGT Patients

NCT00995930 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

189

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Atherosclerosis
Prediabetic State

Interventions

DRUG: ACZ885
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals